SMTL ID : 4aac.1

P38ALPHA MAP KINASE BOUND TO CMPD 29

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x AAV: N-isoxazol-3-yl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxo-quinazolin-3-yl]benzamide(Non-covalent)

AAV.1: 16 residues within 4Å: Chain A: V.35, G.36, S.37, G.38, V.43, A.56, K.58, E.76, L.79, L.80, I.89, T.111, L.172, D.173, F.174, L.176 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.43, A:A.56, A:K.58, A:E.76, A:T.111, A:L.176 Hydrogen bonds: A:E.76, A:E.76, A:T.111, A:D.173, A:F.174 Water bridges: A:A.39 pi-Stacking: A:F.174

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 5 residues within 4Å: Chain A: R.154, D.155, L.156, D.210, S.213 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brown, D.S. et al., The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-05-16

Peptides

MITOGEN-ACTIVATED PROTEIN KINASE 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MITOGEN-ACTIVATED PROTEIN KINASE 14

Related Entries With Identical Sequence